ACAD
ACADIA PHARMACEUTICALS INC · Healthcare · Market cap $4.8B
Insiders sold $1.4M net in the last 90 days ·3 sellers, 0 buyers· 4 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 7, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.5M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Aug 7, 2026
Schneyer Mark C.
ACADIA PHARMACEUTICALS INC (ACAD) has 25 SEC Form 4 filings (53 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 7, 2026.
Inside the rolling window, 6 insiders at ACADIA PHARMACEUTICALS INC reported no open-market purchases and 21 open-market sales totaling $3.5M. The most active filer is EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. with 8 filings. Insiders have net sold $2.4M over the trailing 6 months. The most recent open-market filing is a sale of 5,849 shares by EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C., dated Aug 5, 2026, worth $170K.
- Industry:Biotechnology
- CEO:Catherine E. Owen Adams
- Employees:797
- HQ:San Diego, CA, US
- IPO:2004-05-27
| Source | |||||||
|---|---|---|---|---|---|---|---|
Schneyer Mark C.First in 3 months | EVP, CHIEF FINANCIAL OFFICER | Sale | 5,849 | $170K | Aug 7 | -5.2% | SEC ↗ |
Schneyer Mark C.First in 3 months | EVP, CHIEF FINANCIAL OFFICER | Sale | 14,292 | $418K | Aug 7 | -5.2% | SEC ↗ |
Thompson Elizabeth H.Z.First in 4 months | EVP, Head of Research & Dev | Sale | 16,558 | $433K | Jul 31 | +7.0% | SEC ↗ |
| PRINCIPAL ACCOUNTING OFFICER | Sale | 11,421 | $298K | Jun 29 | +9.8% | SEC ↗ | |
| PRINCIPAL ACCOUNTING OFFICER | Sale | 5,401 | $114K | May 27 | +30.6% | SEC ↗ | |
| PRINCIPAL ACCOUNTING OFFICER | Sale | 1,332 | $29K | May 5 | +23.8% | SEC ↗ | |
| EVP, CHIEF FINANCIAL OFFICER | Sale | 3,506 | $76K | May 5 | +23.8% | SEC ↗ | |
| PRINCIPAL ACCOUNTING OFFICER | Sale | 1,030 | $23K | Apr 7 | +25.3% | SEC ↗ | |
| EVP, CHIEF FINANCIAL OFFICER | Sale | 2,709 | $60K | Apr 7 | — | SEC ↗ | |
Schneyer Mark C.First in 4 months | EVP, CHIEF FINANCIAL OFFICER | Sale | 4,177 | $90K | Mar 26 | — | SEC ↗ |
Schneyer Mark C.First in 4 months | EVP, CHIEF FINANCIAL OFFICER | Sale | 3,208 | $69K | Mar 26 | — | SEC ↗ |
Kihara JamesFirst in 4 months | PRINCIPAL ACCOUNTING OFFICER | Sale | 833 | $18K | Mar 26 | — | SEC ↗ |
Kihara JamesFirst in 4 months | PRINCIPAL ACCOUNTING OFFICER | Sale | 1,109 | $24K | Mar 26 | — | SEC ↗ |
| EVP, CHIEF LEGAL OFFICER, SEC | Sale | 3,844 | $83K | Mar 26 | — | SEC ↗ | |
Thompson Elizabeth H.Z.First filing | EVP, Head of Research & Dev | Sale | 3,435 | $74K | Mar 26 | — | SEC ↗ |
Owen Adams CatherineFirst filing | Chief Executive Officer | Sale | 11,641 | $250K | Mar 26 | — | SEC ↗ |
Rhodes Jennifer JFirst filing | EVP, CHIEF LEGAL OFFICER, SEC | Sale | 6,950 | $162K | Feb 10 | — | SEC ↗ |
| EVP, CHIEF FINANCIAL OFFICER | Sale | 10,262 | $243K | Nov 19 | — | SEC ↗ | |
Kihara JamesFirst filing | PRINCIPAL ACCOUNTING OFFICER | Sale | 4,084 | $97K | Nov 19 | — | SEC ↗ |
Daly James MFirst filing | Director | Sale | 30,000 | $671K | Nov 12 | — | SEC ↗ |
Schneyer Mark C.First filing | EVP, CHIEF FINANCIAL OFFICER | Sale | 3,498 | $83K | Sep 16 | — | SEC ↗ |
Congress trading ACAD 2 all-time
- RRep. Chris JacobsOther$1,001 - $15,0002020-09-08
- DRep. Gilbert Ray CisnerosOther$1,001 - $15,0002019-02-19
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ACAD have?
ACADIA PHARMACEUTICALS INC (ACAD) has 25 SEC Form 4 filings (53 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Aug 7, 2026.
When was the most recent SEC Form 4 filing for ACAD?
The most recent Form 4 filing for ACAD on Tracefour is dated Aug 7, 2026.
Who is the most active insider at ACAD?
The most active SEC Form 4 filer at ACAD in the rolling window is EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C., with 8 filings.
What is the net insider flow at ACAD over the last 6 months?
Over the trailing 180 days, insiders at ACAD have net sold $2.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ACAD in the current window?
Inside the rolling window, insiders at ACAD bought $0 and sold $3.5M based on SEC Form 4 filings.
Can I get alerts for ACAD insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ACADIA PHARMACEUTICALS INC (ACAD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ACADIA PHARMACEUTICALS INC is in the Healthcare sector.